Main | Registration | Speakers | Schedule | Sponsorship | FAQ
Day 1 | Day 2 | Day 3

2021 AAOM Virtual Annual Conference Schedule: Day 2

Day 2: Friday, April 16

Navigate the virtual conference schedule using the links above or below. For any questions, please visit the FAQ page or contact the AAOM office.

Day 1: Thursday, April 15 Day 2: Friday, April 16 | Day 3: Saturday, April 17

Time (Pacific/Eastern) Discussion

Plenary Session 2: Neoplasia: Extending the Frontiers of Knowledge
Moderators: Alessandro Villa, Chelsia Sim

  7:00 – 7:35 AM (PT)
10:00 – 10:35 AM (ET)

Plenary Session 2A | Chimeric Antigen Receptor (CAR) T-cell Therapy: The Current Success and the Future Promises in Combating Hematologic Neoplasia
David Porter, MD

By stimulating the inherent ability of T-cell to combat tumor cells, the 2018 Nobel Laureates have established a breakthrough in cancer therapy. This talk highlights the use of CAR T-cell therapy to treat hematologic neoplasia and other solid tumors and touch on treatment complications that may affect the head and neck area.

Learning Objectives:

  1. Discuss the basic mechanism of action of CAR T-cell therapy and the current clinical evidence of the efficacy/superiority of CAR T-cell therapy.

  2. Elaborate on CAR T-cell therapy toxicity with emphases on the adverse effects in the head and neck region.

  3. Highlight the future directions of this innovative therapeutic approach to combat other forms of cancer including oral squamous cell carcinoma.

  7:35 – 8:10 AM (PT)
10:35 – 11:10 AM (ET)

Plenary Session 2B | Therapeutic implications of the genetic alterations in oral cancer
Jennifer Grandis, MD

This talk provides insight on the current predictors for transformation of oral potentially malignant disorders to oral squamous cell carcinoma and explores genetic alterations in oral cancer.

Learning Objectives:

  1. Familiarize the audience with the biomarkers for oral cancer.
  2. Provide an update on genetic alteration in oral cancer.
  3. Understand the therapeutic implications of PIK3CA alterations in oral cancer.
  8:10 – 8:45 AM (PT)
11:10 – 11:45 AM (ET) 

Plenary Session 2C | Oral Neoplasia in People Living with HIV: Divide, Detect and Conquer
Joel Palefsky, MD

This talk with explore how HIV and HPV may interact to increase the risk of oropharyngeal neoplasia in people living with HIV, and how addressing infection with these viruses may reduce the risk in this particular population.

Learning Objectives:

  1. Understand the epidemiology of oral HPV infection and HPV-associated oropharyngeal neoplasia in people living with HIV infection.

  2. Elaborate on the contemporary approaches for screening, and early detection of oral neoplasia in HIV population and their impact on the disease-related morbidity and mortality.

  3. Display the recent randomized clinical trials conducted to conquer the disease and improve the patients’ overall quality of life.

  8:45 – 9:00 AM (PT)
11:45 – 12:00 PM (ET)
Plenary Session 2 Live Q&A
  9:00 – 9:30 AM
12:00 – 12:30 PM

2020 & 2021 Poster Sessions / Break

  9:30 – 11:00 AM (PT)
12:30 – 2:00 PM (ET) 

Clinicopathologic Expert Panel
Mark Drangsholt, DDS, MPh, PhD; Cameron Randall, PhD; David Tauben, MD
Moderator: David Dean

Pain is a complex multidimensional experience that requires inter-disciplinary assessment and multimodal care. This case conference will bring to the stage experts in variable fields of healthcare, in which two complex orofacial pain cases will be presented. Each had seen multiple providers and yet remained undiagnosed with mounting suffering that had created substantial disability. Attendees will get the chance to participate in live polling throughout this interactive session. Ample time will be designated for more interaction between the audience and the experts’ panel at the end of the session.

Learning Objectives:

  1. Illustrate the use and value of DC TMD pain drawing to detect and diagnose overlapping craniofacial pain conditions.

  2. Illustrate use and importance of the measurement at each visit of functional pain measures such as the PEG scale (Pain intensity, pain interference with Enjoyment of life, General activity).

  3. Discuss and show examples how the biopsychosocial model underlies all clinical encounter and especially those involving orofacial pain.

  11:00 – 12:00 PM (PT)
2:00 – 3:00 PM (ET)
2020 & 2021 Poster Sessions / Long Break
  12:00 – 1:30 PM (PT)
3:00 – 4:30 PM (ET)
Lester Burket Awards Lecture
Moderators: AAOM Abstract Committee
  1:30 – 2:30 PM (PT)
4:30 – 5:30 PM  (ET)

The World Workshop on Oral Medicine

Since the mid 1980’s the World Workshop on Oral Medicine (WWOM) has continued to recruit early and mid-career oral medicine providers to rigorously review the literature and to examine educational standards under the guidance of global experts in oral medicine, and other fields. A decade down the road, the WWOM switched to conducting systematic review with aims to enrich the oral medicine literature with the highest level of evidence-based publications. To accommodate the current growth in the field of oral medicine, the WWOM VIII is now taking a new and unique direction. This lecture will introduce the new World Workshop on Oral Medicine Outcomes Initiative for the Direction of Research (WONDER) and highlight how this initiative will align oral medicine with other medical specialties who have established core outcome sets for the disorders within their specialties. The talk will further explore the feasibility of expanding the scope of oral medicine research by increasing participation and considering a variety of research methods. Audience will be invited to participate in this session via live polling and open discussion with the WWOM panel. 

Learning Objectives:

  1. Provide a historic background of the WWOM and highlight the present expansion in the field of oral medicine that necessitate the changes in the WWOM direction

  2. Announce the launching of the World Workshop on Oral Medicine Outcomes Initiative for the Direction of Research (WONDER) initiative and demonstrate how it will impact oral medicine RCTs and patients’ care

  3. Explore futuristic approaches that may aid in further expansion of oral medicine research 

  2:30 – 5:30 PM (PT)
5:30 – 8:30 PM (ET)

Oral Abstracts 2021 | Self-Study Session
Moderators: AAOM Abstract Committee

  2:30 – 3:30 PM (PT)
5:30 – 8:30 PM (ET)

AAOM Resident Networking

Day 1: Thursday, April 15
 Day 2: Friday, April 16 | Day 3: Saturday, April 17

American Academy of Oral Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.


Attendance American Academy of Oral Medicine designates this activity for 17 continuing education credits.


American Academy of Oral Medicine designates this activity for 14 continuing education credits.